INVO Fertility, Inc. (IVF) Fair Value 2026

IVF · Surgical & Medical Instruments & Apparatus ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.1 /10

32 fundamental signals · 9 models active

Value Trap Risk

WARN (44/100)

Quick Summary — As of 2026-07-13, INVO Fertility, Inc. (IVF) trades at $1.13, approximately 33% below CirclFi’s Bayesian DCF fair value of $1.68. QOC: 5.1/10. Value Trap Risk: 44/100 (WARN). 9/13 models active.

Key Facts

Ticker
IVF
Price
$1.13
Quality Score
5.1/10
Value Trap Risk
44/100
Models Active
9/13
Last Updated
Strength: First Chicago suggests +358.7% upside with 15% confidence
Risk: Value Trap score of 44 suggests caution despite apparent undervaluation

Valuation Matrix

9 Intrinsic Value Models vs. Current Price ($1.13)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Medium Conviction
$1.68 +48.9%
First Chicago
Low Conviction
$5.18 +358.7%
Dynamic NAV
High Conviction
$0.30 -73.5%
PWERM
Medium Conviction
$0.51 -54.8%

Unlock the Full Matrix

Access 5 additional models including ML-RIV, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 9 Models →

Cancel anytime · No contracts · Instant access

What Is INVO Fertility, Inc. (IVF) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, INVO Fertility, Inc.'s intrinsic value is estimated at a composite fair value of $3.06. At a current market price of $1.13, 7 of 9 active valuation models identify upside potential, projecting an average implied return of +171.0%. Notably, Regime Cross sees the most upside at +431.7% (fair value: $6.01), while Dynamic NAV is the most conservative at -73.5% ($0.30). The spread between these extremes — +505.2% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About IVF?

9 of 13 models are currently active for IVF. Of these, 7 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates IVF's intrinsic value at $1.68, implying +48.9% upside from the current price. See which stocks rank higher →

How Does IVF Rank in Surgical & Medical Instruments & Apparatus?

Among 111 Surgical & Medical Instruments & Apparatus stocks, IVF ranks #87 by Quality of Company score. CirclFi's QOC score of 5.1/10 evaluates 32 fundamental signals. A score of 5.1 reflects mixed fundamentals.

See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →

INVO Fertility, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is IVF a Value Trap?

CirclFi's Value Trap algorithm assigns IVF a score of 44/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

9 of 13 models are active for INVO Fertility, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, INVO Fertility, Inc. is rated at 5.1/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.

The gap between the most bullish and bearish model spans +505.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every IVF valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across IVF's 9 active models, average confidence is 28%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy INVO Fertility, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Surgical & Medical Instruments & Apparatus Stocks Should You Also Analyze?

8 related Surgical & Medical Instruments & Apparatus stocks with 13-model coverage

Read investment analysis: DXCM · IRMD · PODD · RMD · WST

See all Surgical & Medical Instruments & Apparatus stocks ranked →

Frequently Asked Questions About INVO Fertility, Inc.

What is INVO Fertility, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, INVO Fertility, Inc. (IVF) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $1.68. The Quality of Company score is 5.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is IVF overvalued or undervalued right now?

At $1.13, 7 of 9 active models suggest IVF may be undervalued, while 2 indicate potential overvaluation. The assessment depends on which methodology best fits INVO Fertility, Inc.'s business model in Surgical & Medical Instruments & Apparatus.

What does a Quality of Company score of 5.1 mean for IVF?

INVO Fertility, Inc.'s QOC of 5.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on IVF?

CirclFi analyzes IVF with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 9 of 13 are active for this stock. Read the full methodology →

Is IVF a value trap in 2026?

INVO Fertility, Inc.'s Value Trap score is 44/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 9 mathematical frameworks give you clarity on IVF.

Unlock All 9 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access